Selection of HER-2/neu-positive tumor cells in early stage cervical cancer: implications for Herceptin-mediated therapy[J] . Stefania Bellone,Michela Palmieri,Murat Gokden,Jabbar Joshua,Juan J Roman,Sergio Pecorelli,Martin J Cannon,Alessandro D Santin.Gynecologic Oncology . 2003 (1)...
6.Antonino Musolino, Nadia Naldi, Beatrice Bortesi, et al. Immunoglobulin G Fragment C Receptor Polymorphisms and Clinical Efficacy of Trastuzumab-Based Therapy in Patients With HER-2/neu–Positive Metastatic Breast Cancer. J Clin Oncol ...
6. Antonino Musolino, Nadia Naldi, Beatrice Bortesi, et al. Immunoglobulin G Fragment C Receptor Polymorphisms and Clinical Efficacy of Trastuzumab-Based Therapy in Patients With HER-2/neu–Positive Metastatic Breast Cancer....
FISH HER-2/neu检测步骤 热度: Is there any advantage to combined trastuzumab and chemotherapy in perioperative setting her 2neu positive localized gastric adenocarcinoma 热度: 比较两种粪便隐血试剂的检测 热度: 176 方法研究 LabeledImmunoassays&ClinMed,Jun.2013,Vo1.20,No.3 ...
AKT2 is frequently upregulated in HER-2/neu-positive breast cancers and may contribute to tumor aggressiveness by enhancing cell survival Testa, AKT2 is frequently upregulated in HER-2/neu-positive breast cancers and may contribute to tumor aggressiveness by enhancing cell sur- vival, ... Sarah...
We evaluated 750 consecutive invasive breast carcinomas for HER-2/neu utilizing a combination of immunohistochemical (IHC) and fluorescence in situ hybridization (FISH) methodologies. IHC reactions of 3+ were considered HER-2/neu positive and 0 and 1+ IHC reactions were considered HER-2/neu ...
HER-2/ neu -positive tumor cells are potentially good targets for tumor-reactive cytotoxic T lymphocytes which have been utilized in immunotherapeutic trials. In addition, the "humanized" monoclonal antibody Herceptin has been tested in several clinical trials and proved to be an effective adjuvant ...
“Efficacy of Margetuximab vs Trastuzumab in Patients With Pretreated ERBB2-Positive Advanced Breast Cancer: A Phase 3 Randomized Clinical Trial.” JAMA oncology vol. 7,4 (2021): 573-584. doi:10.1001/jamaoncol.2020.7932 Tesch, M.E., Gelmon, K.A. Targeting HER2 in Breast Cancer: Latest...
Is there any advantage to combined trastuzumab and chemotherapy in perioperative setting her 2neu positive localized gastric adenocarcinoma 热度: 封面 《用DAKOHercepTest检测肝细胞癌HER-2neu蛋白的表达》 Word格式,可编辑,含目录 内容含:搞要,关键字,正文等。
et al. Danger signals and nonself entity of tumor antigen are both required for eliciting effective immune responses against HER-2/neu positive mammary carcinoma: implications for vaccine design. Cancer Immunol Immunother 57, 1391–1398 (2008). https://doi.org/10.1007/s00262-008-0475-8 Download...